Back to Search Start Over

Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity.

Authors :
Murakami, Yoko
Imaizumi, Toshiyasu
Hashizume, Kouhei
Tezuka, Yu
Oku, Yusuke
Nishiya, Naoyuki
Sanbe, Atsushi
Kurosaka, Daijiro
Source :
Journal of Ocular Pharmacology & Therapeutics. May2024, Vol. 40 Issue 4, p246-252. 7p.
Publication Year :
2024

Abstract

Purpose: To investigate the effect of yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) on connective tissue growth factor (CTGF) expression in adult retinal pigment epithelial (ARPE)-19 cells. We also studied the inhibitory effect of K-975, a new pan-transcriptional enhanced associate domain (TEAD) inhibitor, and luteolin, a plant-derived flavonoid on CTGF expression. Methods: ARPE-19 cells were transfected with either YAP or TAZ overexpression plasmid or treated with transforming growth factor (TGF)-β2. The cells were cultured either with or without K-975 or luteolin. The expression of YAP, TAZ, and CTGF was examined using real-time PCR. Results: ARPE-19 cells overexpressing YAP or TAZ exhibited significantly increased CTGF expression. This increase was attenuated by K-975 or luteolin alone. TGF-β2 treatment significantly raised the expression of not just YAP and TAZ, but also CTGF in ARPE-19 cells. TGF-β2 treatment-enhanced CTGF expression was considerably lowered by the addition of K-975 or luteolin. Conclusions: Overexpression of YAP or TAZ and treatment with TGF-β2 led to an increase in the expression of CTGF in ARPE-19 cells. These increases were attenuated by treatment with K-975 and luteolin. These findings suggest that YAP and TAZ may be related to the expression of CTGF in ARPE-19 cells and that K-975 and luteolin can be explored as potential therapeutic agents for preventing CTGF production in vitreoretinal fibrosis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10807683
Volume :
40
Issue :
4
Database :
Academic Search Index
Journal :
Journal of Ocular Pharmacology & Therapeutics
Publication Type :
Academic Journal
Accession number :
177399834
Full Text :
https://doi.org/10.1089/jop.2023.0141